Is Female Sex Really a Risk Factor for Infectious Death in Peritoneal Dialysis?

McDonald S.P. , Hurst K. ANZDATA Registry Report 2012. Adelaide, South Australia: Australian and New Zealand Dialysis and Transplant Registry; 2013.

United States, Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, US Renal Data System (USRDS). USRDS 2012 Annual Data Report. Bethesda, MD: USRDS; 2012.

Johnson D.W. , Dent H. , Hawley C.M. , McDonald S.P. , Rosman J.B. , Brown F. Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. Am J Kidney Dis 2009; 53: 290–7.

Ghali J.R. , Bannister K. , Brown F.G. , Rosman J.B. , Wiggins K.J. , Johnson D.W. Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int 2011; 31: 651–62.

Lim W.H. , Boudville N. , McDonald S.P. , Gorham G. , Johnson D.W. , Jose M. Remote indigenous peritoneal dialysis patients have higher risk of peritonitis, technique failure, all-cause and peritonitis-related mortality. Nephrol Dial transplant 2011; 26: 3366–72.

McDonald S.P. , Collins J. , Rumpsfeld M. , Johnson D.W. Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int 2004; 24: 340–6.

Piraino B. , Bernardini J. , Brown E. , Figueiredo A. , Johnson D.W. , Lye W.C. ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int 2011; 31: 614–30.

Kerschbaum J. , Konig P. , Rudnicki M. Risk factors associated with peritoneal-dialysis-related peritonitis. Int J Nephrol 2012; 2012: 483250.

Ros S. , Remón C. , Qureshi A.R. , Quiros P. , Lindholm B. , Carrero J.J. Increased risk of fatal infections in women starting peritoneal dialysis. Perit Dial Int 2013; 33: 487–494.

Pérez Fontan M. , Rodríguez-Carmona A. , García-Naveiro R. , Rosales M. , Villaverde P. , Valdés F. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int 2005; 25: 274–84.

Kotsanas D. , Polkinghorne K.R. , Korman T.M. , Atkins R.C. , Brown F. Risk factors for peritoneal dialysis-related peritonitis: can we reduce the incidence and improve patient selection? Nephrology (Carlton) 2007; 12: 239–45.

Oygar D.D. , Yalin A.S. , Altiparmak M.R. , Ataman R. , Serdengecti K. Obligatory referral among other factors associated with peritonitis in peritoneal dialysis patients. Nefrologia 2011; 31: 435–40.

Nessim S.J. , Bargman J.M. , Austin P.C. , Nisenbaum R. , Jassal S.V. Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database. Clin J Am Soc Nephrol 2009; 4: 1195–200.

Oo T.N. , Roberts T.L. , Collins A.J. A comparison of peritonitis rates from the United States Renal Data System database: CAPD versus continuous cycling peritoneal dialysis patients. Am J Kidney Dis 2005; 45: 372–80.

Martin L.C. , Caramori J.C. , Fernandes N. , Divino-Filho J.C. , Pecoits-Filho R. , Barretti P. on behalf of the Brazilian Peritoneal Dialysis Multicenter Study BRAZPD Group. Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis study (BRAZPD) patients. Clin J Am Soc Nephrol 2011; 6: 1944–51.

Lobo J.V. , Villar K.R. , de Andrade Júnior M.P. , Bastos Kde A. Predictor factors of peritoneal dialysis-related peritonitis. J Bras Nefrol 2010; 32: 156–64. [Erratum in: J Bras Nefrol 2010; 32:332]

Rudnicki M. , Kerschbaum J. , Hausdorfer J. , Mayer G. , König P. Risk factors for peritoneal dialysis-associated peritonitis: the role of oral active vitamin D. Perit Dial Int 2010; 30: 541–8.

Chern Y.B. , Ho P.S. , Kuo L.C. , Chen J.B. Lower education level is a major risk factor for peritonitis incidence in chronic peritoneal dialysis patients: a retrospective cohort study with 12-year follow-up. Perit Dial Int 2013; 33: 552–558.

Krishnan M. , Thodis E. , Ikonomopoulos D. , Vidgen E. , Chu M. , Bargman J.M. Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int 2002; 22: 573–81.

Cho Y. , Badve S.V. , Hawley C.M. , McDonald S.P. , Brown F.G. , Boudville N. Effects of climatic region on peritonitis risk, microbiology, treatment, and outcomes: a multi-center registry study. Perit Dial Int 2013; 33: 75–85.

Lim W.H. , Johnson D.W. , McDonald S.P. Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA. Nephrology (Carlton) 2005; 10: 192–7.

Cho Y. , Badve S.V. , Hawley C.M. , McDonald S.P. , Brown F.G. , MN.B. et al. The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-centre registry study. BMC Nephrol 2012; 13: 41.

Johnson D.W. , Clayton P. , Cho Y. , Badve S.V. , Hawley C.M. , McDonald S. Weekend compared with weekday presentations of peritoneal dialysis-associated peritonitis. Perit Dial Int 2012; 32: 516–24.

Cho Y. , Badve S.V. , Hawley C.M. , McDonald S.P. , Brown F.G. , Boudville N. Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes. Clin J Am Soc Nephrol 2013: [Epub ahead of print].

O'Shea S. , Hawley C.M. , McDonald S.P. , Brown F.G. , Rosman J.B. , Wiggins K.J. Streptococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 287 cases. BMC Nephrol 2009; 10: 19.

Govindarajulu S. , Hawley C.M. , McDonald S.P. , Brown F.G. , Rosman J.B. , Wiggins K.J. Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases. Perit Dial Int 2010; 30: 311–19.

Fahim M. , Hawley C.M. , McDonald S.P. , Brown F.G. , Rosman J.B. , Wiggins K.J. Coagulase-negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 936 cases. Nephrol Dial transplant 2010; 25: 3386–92.

Edey M. , Hawley C.M. , McDonald S.P. , Brown F.G. , Rosman J.B. , Wiggins K.J. Enterococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 116 cases. Nephrol Dial transplant 2010; 25: 1272–8.

Barraclough K. , Hawley C.M. , McDonald S.P. , Brown F.G. , Rosman J.B. , Wiggins K.J. Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases. Nephrol Dial transplant 2009; 24: 3834–9.

Fahim M. , Hawley C.M. , McDonald S.P. , Brown F.G. , Rosman J.B. , Wiggins K.J. Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases. Am J Kidney Dis 2010; 55: 690–7.

Siva B. , Hawley C.M. , McDonald S.P. , Brown F.G. , Rosman J.B. , Wiggins K.J. Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin J Am Soc Nephrol 2009; 4: 957–64.

Jarvis E.M. , Hawley C.M. , McDonald S.P. , Brown F.G. , Rosman J.B. , Wiggins K.J. Predictors, treatment, and outcomes of non-Pseudomonas gram-negative peritonitis. Kidney Int 2010; 78: 408–14.

Barraclough K. , Hawley C.M. , McDonald S.P. , Brown F.G. , Rosman J.B. , Wiggins K.J. Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes. Am J Kidney Dis 2010; 55: 121–31.

Miles R. , Hawley C.M. , McDonald S.P. , Brown F.G. , Rosman J.B. , Wiggins K.J. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int 2009; 76: 622–8.